AIM ImmunoTech Inc

AIM ImmunoTech Director CHEMEROW David I. Plugs Into Rights Offering, Snags 25 Preferred Shares & 50,000 Free Warrants Amid Stock Slump

Insider CHEMEROW buys AIM ImmunoTech preferred shares & free warrants amid a rights offering, signaling confidence in the company’s cancer‑therapy pipeline.

AIM ImmunoTech Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

10/03/2026, 23:14

3 minutes to read

Insider Buying Signals: AIM ImmunoTech Director Buys Shares Amid Falling Stock, Hinting at Confidence in Future Pipeline

Insider buying signals at AIM ImmunoTech: owner David Chemerow purchases shares below 1.23 USD, hinting confidence amid a steep decline and upcoming rights offering.

AIM ImmunoTech Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

06/02/2026, 23:19

3 minutes to read